PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v7i2.4788ArticleValue of N-Terminal Pro B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Homocysteine Levels in Predicting Cardiovascular Events in Chronic Heart Failure Patients After Dischargehttps://artdesignp.com/journal/PAR/7/2/10.26689/par.v7i2.4788YuQian,ZhaoLinya,ChenYinyin,ZhaoQing2023722023-03-30Objective: To investigate the value of N-terminal pro B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), and homocysteine (Hcy) levels in predicting cardiovascular events (CV) in patients with chronic heart failure (CHF). Methods: A total of 63 patients with CHF admitted to our hospital between June 2019 and July 2021 were selected. Their NT-proBNP, hs-CRP, and Hcy levels were detected at discharge, and a 12-month follow-up was done after their discharge to collect clinical data. The collected data were inclusive of data from 21 CHF patients with cardiovascular disease and 42 CHF patients without cardiovascular disease. The effect of NT-proBNP, hs-CRP, and Hcy levels on the occurrence of CV was analyzed. Results: The levels of NT-proBNP, hs-CRP, and Hcy in the group with cardiovascular disease were significantly higher than those in the group without cardiovascular disease (P < 0.05); the levels of serum NT-proBNP, hs-CRP, and Hcy at discharge had certain value in predicting short-term CV in CHF patients (P < 0.05). Conclusion: NT-proBNP, hs-CRP, and Hcy levels can be used to predict CV in CHF patients, thus having clinical application value.

Wan C, 2022, Association of Serum UA, D-D, and Peptide, HGF with NYHA Cardiac Function Class and Cardiovascular Events in CHF Patients. Chinese Health Engineering, 21(05): 799–802.

Ren S, Tian Z, Xu D, 2022, Serum hsTn?, MMP-9, sST2 Expression Levels and Their Clinical Significance in Elderly Patients with Chronic Heart Failure. Henan Medical Research, 31(13): 2373–2376.

Zhao D, Zhao Y, Yu M, et al., 2022, Value of Serum NGAL Levels in the Evaluation of Cardiac Function and Prediction of Major Cardiovascular Adverse Events in Patients with Chronic Heart Failure. Chinese Experimental Diagnostics, 26(03): 374–378.

Yu Q, 2022, Study on the Value of Heart Failure Biomarkers in the Application of Chronic Heart Failure in the Elderly, thesis, Anhui Medical University.

Meng J, He T, Li H, et al., 2021, Study on the Relationship Between Thyroid Hormone Levels and Cognitive Function, Cardiac Function and Cardiovascular Events in Elderly Patients with Chronic Heart Failure. Modern Biomedical Progress, 21(23): 4531–4535.

Yuan Y, Qi S, Wang Y, et al., 2021, Impact of Iron Deficiency on Quality of Life and Predictive Value of Recent Major Adverse Cardiovascular Events in Patients with Chronic Heart Failure. Lingnan Journal of Cardiovascular Diseases, 27(06): 688–692 + 718.

Yang Y, Li M, 2021, Predictive Value of Serum Periostin Protein and Hepatocyte Growth Factor on Cardiovascular Events in Patients with Chronic Heart Failure. Journal of Heart, 33(02): 156–159 + 164.

Li X, Zhu W, Jiang F, 2017, Correlation Between Echocardiographic Function Indices and Serum Hcy in Patients with Chronic Heart Failure. Journal of Practical Medicine, 33(04): 579–582.

Wang Z, 2020, Study on Prognostic Assessment of Traditional Risk Factors Combined with sST2 in Patients with Chronic Heart Failure, thesis, Jilin University.

Chen W, Wu Z, Zhang Y, et al., 2020, Association of Elevated Serum S100B Levels with Clinical Severity, Impaired Renal Function and Cardiovascular Primary Endpoint Events in Patients with Chronic Heart Failure. Chinese Journal of Gerontology, 40(08): 1569–1572.

Chen Y, Wang D, 2019, The relationship Between Serum Apoa-1 and the Severity of Chronic Heart Failure and Its Prognosis. Zhejiang Medicine, 41(04): 332–336.

Wang Y, Yu H, 2020, The Role of Stepwise Exercise with Continuous Weight Intervention in Strengthening Cardiac Function and Reducing the Incidence of Adverse Cardiovascular Events in Patients with Chronic Heart Failure. Nursing Practice and Research, 17(24): 57–59.

He J, 2014, Situational Analysis of the Effects of Renal Anemia and Ultrasensitive C-Reactive Protein on Cardiovascular Complications in Patients with Chronic Kidney Disease, thesis, Guangxi Medical University.

Zou R, He L, Xiao F, et al., 2012, Comparison of the Prevalence of Cardiovascular Disease in Patients on Peritoneal Dialysis and Hemodialysis and Analysis of Influencing Factors. Chinese Journal of Clinical Physicians (Electronic Edition), 6(18): 5515–5519.

Hou F, Ma Z, Mei C, et al., 2005, Investigation of Risk Factors for Cardiovascular Disease in Patients with Chronic Kidney Disease in Five Provinces, Cities and Autonomous Regions of China. Chinese Medical Journal, 2005(11): 753–759.